SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $65 | $62 | $48 | $40 |
| % Growth | 4.5% | 31.1% | 17.6% | – |
| Cost of Goods Sold | $21 | $19 | $16 | $15 |
| Gross Profit | $44 | $43 | $31 | $25 |
| % Margin | 67.4% | 68.8% | 65.7% | 62.4% |
| R&D Expenses | $34 | $37 | $35 | $27 |
| G&A Expenses | $47 | $53 | $56 | $42 |
| SG&A Expenses | $76 | $82 | $84 | $70 |
| Sales & Mktg Exp. | $29 | $28 | $28 | $29 |
| Other Operating Expenses | -$0 | -$1 | -$0 | -$0 |
| Operating Expenses | $111 | $118 | $119 | $97 |
| Operating Income | -$67 | -$75 | -$88 | -$71 |
| % Margin | -102.1% | -120% | -184.7% | -176.7% |
| Other Income/Exp. Net | $5 | -$4 | $0 | -$2 |
| Pre-Tax Income | -$61 | -$78 | -$88 | -$74 |
| Tax Expense | $1 | $0 | -$0 | $0 |
| Net Income | -$62 | -$79 | -$87 | -$74 |
| % Margin | -95.9% | -126.6% | -183.9% | -182.1% |
| EPS | -0.95 | -1.22 | -1.36 | -1.33 |
| % Growth | 22.1% | 10.3% | -2.3% | – |
| EPS Diluted | -0.95 | -1.22 | -1.36 | -1.33 |
| Weighted Avg Shares Out | 66 | 65 | 64 | 55 |
| Weighted Avg Shares Out Dil | 66 | 65 | 64 | 55 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $5 | $1 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $9 | $8 | $6 | $4 |
| EBITDA | -$51 | -$70 | -$81 | -$69 |
| % Margin | -77.9% | -111.5% | -171.1% | -171.2% |